Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $338.29 | $19.40 | 1,643.83% | 6,765.80x | 101.40x | 7.50x | 9.07x | 6.54x | $529.27M | 1.42% | $4.13B | 37.48 | $35.34B | 111.12 | ||
| NVO | NOVO NORDISK A S | $57.12 | $149.89 | -61.89% | 15.88x | 2.48x | 5.22x | 9.70x | 0.16x | $9.34B | 3.68% | $26.18B | 5.89 | $264.46B | 10.66 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $359.26 | $37.02 | 870.52% | 1,158.90x | 51.63x | 14.71x | 202.93x | 3.77x | $221.36M | 0.47% | $233.89M | 1.78 | $49.19B | 323.75 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $37.92 | $17.46 | 117.14% | 77.39x | 22.04x | 4.74x | 5.37x | 0.96x | $101.73M | 3.59% | $535.38M | 7.17 | $2.71B | 50.56 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $9.02 | $16.54 | -45.48% | 18.79x | 15.86x | 5.98x | 3.81x | 0.24x | -$23.64M | -4.69% | $133.17M | 2.38 | $516.08M | 7.68 | ||
| CORT | CORCEPT THERAPEUTICS INC | $35.39 | $43.42 | -18.49% | 35.39x | 32.20x | 4.94x | 5.89x | 0.35x | $162.57M | 4.44% | $631.90M | 6.10 | $3.60B | 54.62 | ||
| VCEL | VERICEL CORP | $38.57 | $9.61 | 301.34% | 148.35x | 66.34x | 7.53x | 6.06x | 1.76x | $20.38M | 1.05% | $321.86M | 6.38 | $1.95B | 66.47 | ||
| ARGX | ARGENX SE | $813.24 | $364.73 | 122.97% | 32.50x | 27.55x | 26,233.55x | 6.92x | 1.37x | $467.72M | 0.94% | $7.17B | 117.50 | $47.23B | 58.22 | ||
| KRYS | KRYSTAL BIOTECH INC | $282.01 | $116.61 | 141.83% | 40.87x | 35.15x | 21.88x | 7.19x | 1.36x | $166.02M | 2.03% | $1.14B | 39.30 | $7.79B | 40.32 | ||
| TECH | BIO-TECHNE CORP | $69.96 | $16.41 | 326.45% | 139.92x | 34.60x | 8.94x | 5.55x | 1.91x | $224.06M | 2.06% | $1.97B | 12.65 | $11.15B | 50.48 | ||
| GMAB | GENMAB A | $33.85 | $129.00 | -73.76% | 14.45x | 1.93x | 6.10x | 3.78x | 0.11x | $1.19B | 5.49% | $5.75B | 8.96 | $20.11B | 10.05 | ||
| ABEO | ABEONA THERAPEUTICS INC | $5.45 | $19.25 | -71.68% | 3.43x | -101.11x | 778.57x | 1.72x | 0.20x | -$82.36M | -27.85% | $171.23M | 3.16 | $236.23M | 2.63 | ||
| ADMA | ADMA BIOLOGICS INC | $17.50 | $12.82 | 36.51% | 19.89x | 19.50x | 8.54x | 9.66x | 0.84x | $40.73M | 0.98% | $431.19M | 1.81 | $4.18B | 24.27 | ||
| XOMA | XOMA ROYALTY CORP | $28.79 | $15.96 | 80.39% | 35.54x | 91.57x | 7.42x | 4.05x | 0.94x | -$12.41M | -3.55% | $87.94M | 7.25 | $397.95M | 14.88 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $14.87 | $9.92 | 49.94% | 25.64x | 15.59x | 7.37x | 5.36x | 0.84x | $119.87M | 6.11% | $365.77M | 2.78 | $1.97B | 18.99 | ||
| VCYT | VERACYTE INC | $41.00 | $12.42 | 230.13% | 105.13x | 38.97x | 6.52x | 2.58x | 1.49x | $98.21M | 3.04% | $1.26B | 15.98 | $2.96B | 52.01 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $196.08 | $72.86 | 169.11% | 84.88x | 23.30x | 15.28x | 4.06x | 1.22x | $30.76M | 0.80% | $950.17M | 48.53 | $4.17B | 40.49 | ||
| CRMD | CORMEDIX INC | $7.01 | $17.96 | -60.97% | 3.09x | 2.78x | 2.48x | 1.48x | 0.54x | $74.42M | 13.98% | $374.13M | 4.93 | $652.74M | 5.81 | ||
| MNKD | MANNKIND CORP | $5.58 | $2.80 | 99.22% | 55.80x | 50.87x | 5.45x | -38.46x | 0.93x | $43.39M | 2.53% | -$44.55M | -0.15 | $1.95B | 26.59 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $6.31 | $4.35 | 44.93% | 23.37x | 20.97x | 4.04x | 7.13x | 0.83x | $21.15M | 4.20% | $70.68M | 0.89 | $442.34M | 19.49 | ||
| RPRX | ROYALTY PHARMA PLC | $39.72 | $47.57 | -16.51% | 22.57x | 7.67x | 7.30x | 2.38x | 0.39x | $2.11B | 12.31% | $9.62B | 22.28 | $30.93B | 29.62 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $36.41 | $61.69 | -40.98% | 11.27x | 8.62x | 2.54x | 2.51x | 0.31x | $296.89M | 14.17% | $835.12M | 14.51 | $1.62B | 6.00 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $438.92 | $191.86 | 128.77% | 30.67x | 21.46x | 9.57x | 6.43x | 1.49x | $3.34B | 2.97% | $17.32B | 67.76 | $108.26B | 23.22 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $2.06 | $3.60 | -42.77% | 29.43x | 11.65x | 2.64x | 3.13x | 0.24x | -$11.69M | -7.14% | $52.91M | 0.67 | $160.20M | 18.06 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $55.07 | $51.79 | 6.32% | 20.25x | 12.22x | 3.42x | 1.75x | 0.56x | $832.13M | 7.87% | $6.06B | 31.54 | $9.93B | 12.85 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $20.53 | $6.73 | 205.16% | 58.66x | -18.49x | 2.55x | 6.47x | 1.61x | $78.64M | 3.03% | $401.17M | 3.17 | $2.59B | 27.76 | ||
| EXEL | EXELIXIS INC | $45.44 | $36.84 | 23.33% | 18.47x | 14.38x | 5.33x | 5.64x | 0.74x | $779.77M | 6.39% | $2.16B | 8.05 | $11.98B | 12.92 | ||
| HALO | HALOZYME THERAPEUTICS INC | $71.82 | $81.39 | -11.76% | 14.69x | 8.66x | 6.77x | 16.76x | 0.50x | $602.40M | 7.16% | $503.92M | 4.30 | $9.54B | 11.28 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $22.96 | $22.81 | 0.65% | 12.83x | 11.77x | 4.87x | 3.07x | 0.68x | $234.54M | 8.33% | $920.25M | 7.51 | $2.13B | 6.59 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $741.92 | $415.73 | 78.46% | 17.08x | 16.11x | 5.39x | 2.52x | 1.67x | $4.22B | 5.49% | $30.96B | 298.82 | $78.17B | 13.69 | ||
| MDXG | MIMEDX GROUP INC | $5.75 | $5.10 | 12.80% | 20.54x | 23.01x | 2.16x | 3.56x | 0.61x | $66.82M | 7.84% | $238.95M | 1.61 | $727.72M | 10.51 | ||
| INVA | INNOVIVA INC | $19.76 | $19.54 | 1.15% | 10.46x | 9.04x | 3.51x | 1.46x | 0.85x | $196.54M | 14.40% | $1.01B | 14.63 | $1.26B | 5.86 | ||
| UTHR | UNITED THERAPEUTICS CORP | $471.99 | $253.30 | 86.33% | 16.57x | 15.86x | 6.61x | 3.08x | 1.97x | $1.12B | 5.43% | $6.59B | 150.46 | $18.98B | 10.71 | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $26.53 | $12.45 | 113.07% | 16.90x | 32.95x | 4.28x | 4.89x | 2.91x | $197.81M | 4.42% | $917.27M | 5.43 | $4.26B | 14.82 | ||
| INCY | INCYTE CORP | $105.24 | $77.95 | 35.02% | 17.42x | 13.08x | 4.28x | 4.44x | 0.90x | $1.20B | 5.81% | $4.65B | 23.77 | $18.24B | 10.84 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.